• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞色素P450 46A1(CYP46A1)介导的胆固醇清除缺陷小鼠大脑中的转录和翻译后变化。

Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1).

作者信息

Mast Natalia, Lin Joseph B, Anderson Kyle W, Bjorkhem Ingemar, Pikuleva Irina A

机构信息

Department of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, Ohio, United States of America.

Biomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, Maryland, United States of America.

出版信息

PLoS One. 2017 Oct 26;12(10):e0187168. doi: 10.1371/journal.pone.0187168. eCollection 2017.

DOI:10.1371/journal.pone.0187168
PMID:29073233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5658173/
Abstract

Cytochrome P450 46A1 (CYP46A1) converts cholesterol to 24-hydroxycholesterol and thereby controls the major pathways of cholesterol removal from the brain. Cyp46a1-/- mice have a reduction in the rate of cholesterol biosynthesis in the brain and significant impairments to memory and learning. To gain insights into the mechanisms underlying Cyp46a1-/- phenotype, we used Cyp46a1-/- mice and quantified their brain sterol levels and the expression of the genes pertinent to cholesterol homeostasis. We also compared the Cyp46a1-/- and wild type brains for protein phosphorylation and ubiquitination. The data obtained enable the following inferences. First, there seems to be a compensatory upregulation in the Cyp46a1-/- brain of the pathways of cholesterol storage and CYP46A1-independent removal. Second, transcriptional regulation of the brain cholesterol biosynthesis via sterol regulatory element binding transcription factors is not significantly activated in the Cyp46a1-/- brain to explain a compensatory decrease in cholesterol biosynthesis. Third, some of the liver X receptor target genes (Abca1) are paradoxically upregulated in the Cyp46a1-/- brain, possibly due to a reduced activation of the small GTPases RAB8, CDC42, and RAC as a result of a reduced phosphorylation of RAB3IP and PAK1. Fourth, the phosphorylation of many other proteins (a total of 146) is altered in the Cyp46a1-/- brain, including microtubule associated and neurofilament proteins (the MAP and NEF families) along with proteins related to synaptic vesicles and synaptic neurotransmission (e.g., SLCs, SHANKs, and BSN). Fifth, the extent of protein ubiquitination is increased in the Cyp46a1-/- brain, and the affected proteins pertain to ubiquitination (UBE2N), cognition (STX1B and ATP1A2), cytoskeleton function (TUBA1A and YWHAZ), and energy production (ATP1A2 and ALDOA). The present study demonstrates the diverse potential effects of CYP46A1 deficiency on brain functions and identifies important proteins that could be affected by this deficiency.

摘要

细胞色素P450 46A1(CYP46A1)将胆固醇转化为24-羟基胆固醇,从而控制胆固醇从大脑清除的主要途径。Cyp46a1基因敲除小鼠大脑中的胆固醇生物合成速率降低,且记忆和学习能力有显著损伤。为深入了解Cyp46a1基因敲除小鼠表型背后的机制,我们使用了Cyp46a1基因敲除小鼠,对其大脑中的甾醇水平以及与胆固醇稳态相关的基因表达进行了定量分析。我们还比较了Cyp46a1基因敲除小鼠和野生型小鼠大脑中的蛋白质磷酸化和泛素化情况。所获得的数据得出了以下推论。首先,在Cyp46a1基因敲除小鼠的大脑中,胆固醇储存途径和不依赖CYP46A1的清除途径似乎存在代偿性上调。其次,在Cyp46a1基因敲除小鼠的大脑中,通过甾醇调节元件结合转录因子对大脑胆固醇生物合成的转录调控并未被显著激活,无法解释胆固醇生物合成的代偿性降低。第三,一些肝脏X受体靶基因(Abca1)在Cyp46a1基因敲除小鼠的大脑中反而上调,这可能是由于RAB3IP和PAK1磷酸化减少导致小GTP酶RAB8、CDC42和RAC的激活降低所致。第四,在Cyp46a1基因敲除小鼠的大脑中,许多其他蛋白质(总共146种)的磷酸化发生了改变,包括微管相关蛋白和神经丝蛋白(MAP和NEF家族)以及与突触小泡和突触神经传递相关的蛋白质(如SLCs、SHANKs和BSN)。第五,在Cyp46a1基因敲除小鼠的大脑中,蛋白质泛素化程度增加,受影响的蛋白质涉及泛素化(UBE2N)、认知(STX1B和ATP1A2)、细胞骨架功能(TUBA1A和YWHAZ)以及能量产生(ATP1A2和ALDOA)。本研究证明了CYP46A1缺乏对大脑功能的多种潜在影响,并确定了可能受这种缺乏影响的重要蛋白质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafe/5658173/7cd413583f26/pone.0187168.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafe/5658173/15ddc2672f19/pone.0187168.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafe/5658173/4b6c4d0223d7/pone.0187168.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafe/5658173/c36e0bfa027d/pone.0187168.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafe/5658173/7558b6c08978/pone.0187168.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafe/5658173/7cd413583f26/pone.0187168.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafe/5658173/15ddc2672f19/pone.0187168.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafe/5658173/4b6c4d0223d7/pone.0187168.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafe/5658173/c36e0bfa027d/pone.0187168.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafe/5658173/7558b6c08978/pone.0187168.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafe/5658173/7cd413583f26/pone.0187168.g005.jpg

相似文献

1
Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1).细胞色素P450 46A1(CYP46A1)介导的胆固醇清除缺陷小鼠大脑中的转录和翻译后变化。
PLoS One. 2017 Oct 26;12(10):e0187168. doi: 10.1371/journal.pone.0187168. eCollection 2017.
2
Brain Acetyl-CoA Production and Phosphorylation of Cytoskeletal Proteins Are Targets of CYP46A1 Activity Modulation and Altered Sterol Flux.脑乙酰辅酶 A 生成和细胞骨架蛋白磷酸化是 CYP46A1 活性调节和固醇通量改变的靶点。
Neurotherapeutics. 2021 Jul;18(3):2040-2060. doi: 10.1007/s13311-021-01079-6. Epub 2021 Jul 7.
3
CYP46A1-dependent and independent effects of efavirenz treatment.依法韦仑治疗的CYP46A1依赖性和非依赖性效应。
Brain Commun. 2020 Oct 29;2(2):fcaa180. doi: 10.1093/braincomms/fcaa180. eCollection 2020.
4
Retinal Vascular Abnormalities and Microglia Activation in Mice with Deficiency in Cytochrome P450 46A1-Mediated Cholesterol Removal.缺乏细胞色素 P450 46A1 介导的胆固醇清除导致的小鼠视网膜血管异常和小胶质细胞激活。
Am J Pathol. 2019 Feb;189(2):405-425. doi: 10.1016/j.ajpath.2018.10.013. Epub 2018 Nov 16.
5
Brain sterol flux mediated by cytochrome P450 46A1 affects membrane properties and membrane-dependent processes.细胞色素P450 46A1介导的脑甾醇通量影响膜特性和膜依赖性过程。
Brain Commun. 2020;2(1). doi: 10.1093/braincomms/fcaa043. Epub 2020 Apr 11.
6
Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases.CYP46A1 介导的胆固醇 24-羟化作用:调控对脑部疾病的益处。
Neurotherapeutics. 2019 Jul;16(3):635-648. doi: 10.1007/s13311-019-00731-6.
7
Cytochrome P450 27A1 Deficiency and Regional Differences in Brain Sterol Metabolism Cause Preferential Cholestanol Accumulation in the Cerebellum.细胞色素P450 27A1缺乏与脑甾醇代谢的区域差异导致小脑优先积累胆固醇。
J Biol Chem. 2017 Mar 24;292(12):4913-4924. doi: 10.1074/jbc.M116.774760. Epub 2017 Feb 11.
8
The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment.依非韦伦激活 CYP46A1 减少淀粉样蛋白的作用模式中受影响的关键基因、磷酸化蛋白、过程和途径。
FASEB J. 2019 Aug;33(8):8782-8798. doi: 10.1096/fj.201900092R. Epub 2019 May 7.
9
cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds.神经活性化合物对细胞色素P450 46A1(CYP46A1)的激活作用。
J Biol Chem. 2017 Aug 4;292(31):12934-12946. doi: 10.1074/jbc.M117.794909. Epub 2017 Jun 22.
10
Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease.胆固醇代谢酶细胞色素P450 46A1作为阿尔茨海默病的药物靶点。
Neuropharmacology. 2017 Sep 1;123:465-476. doi: 10.1016/j.neuropharm.2017.06.026. Epub 2017 Jun 24.

引用本文的文献

1
Effects of Complete and Partial Loss of the 24S-Hydroxycholesterol-Generating Enzyme on Behavior and Hippocampal Transcription in Mouse.24S-羟胆固醇生成酶完全缺失和部分缺失对小鼠行为和海马转录的影响。
Biomolecules. 2024 Feb 21;14(3):254. doi: 10.3390/biom14030254.
2
Tissue-Specific Oxysterols as Predictors of Antidepressant (Escitalopram) Treatment Response in Patients With Major Depressive Disorder.组织特异性氧化甾醇作为重度抑郁症患者抗抑郁药(艾司西酞普兰)治疗反应的预测指标
Biol Psychiatry Glob Open Sci. 2023 Jan 30;3(4):663-672. doi: 10.1016/j.bpsgos.2023.01.004. eCollection 2023 Oct.
3
The translational potential of cholesterol-based therapies for neurological disease.

本文引用的文献

1
Neuronal Stimulation Triggers Neuronal Glycolysis and Not Lactate Uptake.神经元刺激引发神经元糖酵解而非乳酸摄取。
Cell Metab. 2017 Aug 1;26(2):361-374.e4. doi: 10.1016/j.cmet.2017.06.021.
2
Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease.胆固醇代谢酶细胞色素P450 46A1作为阿尔茨海默病的药物靶点。
Neuropharmacology. 2017 Sep 1;123:465-476. doi: 10.1016/j.neuropharm.2017.06.026. Epub 2017 Jun 24.
3
cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds.神经活性化合物对细胞色素P450 46A1(CYP46A1)的激活作用。
胆固醇类疗法治疗神经疾病的转化潜力。
Nat Rev Neurol. 2023 Oct;19(10):583-598. doi: 10.1038/s41582-023-00864-5. Epub 2023 Aug 29.
4
24-Hydroxycholesterol Moderates the Effects of Amyloid-β on Expression of HMG-CoA Reductase and ABCA1 Proteins in Mouse Astrocytes.24-羟基胆固醇调节淀粉样蛋白-β对小鼠星形胶质细胞中HMG-CoA还原酶和ABCA1蛋白表达的影响。
Adv Biomed Res. 2023 Jun 30;12:167. doi: 10.4103/abr.abr_245_22. eCollection 2023.
5
Investigation of Potential Drug Targets for Cholesterol Regulation to Treat Alzheimer's Disease.探讨调节胆固醇以治疗阿尔茨海默病的潜在药物靶点。
Int J Environ Res Public Health. 2023 Jun 24;20(13):6217. doi: 10.3390/ijerph20136217.
6
Lipolysis-Stimulated Lipoprotein Receptor Acts as Sensor to Regulate ApoE Release in Astrocytes.脂解刺激脂蛋白受体作为传感器调节星形细胞中载脂蛋白 E 的释放。
Int J Mol Sci. 2022 Aug 3;23(15):8630. doi: 10.3390/ijms23158630.
7
Altered Cholesterol Homeostasis in Huntington's Disease.亨廷顿舞蹈病中胆固醇稳态的改变
Front Aging Neurosci. 2022 Apr 19;14:797220. doi: 10.3389/fnagi.2022.797220. eCollection 2022.
8
Targeting cytochrome P450 46A1 and brain cholesterol 24-hydroxylation to treat neurodegenerative diseases.靶向细胞色素P450 46A1和脑胆固醇24-羟化作用以治疗神经退行性疾病。
Explor Neuroprotective Ther. 2021 Dec 30;1(3):159-172. doi: 10.37349/ent.2021.00013.
9
Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications.胆固醇羟化细胞色素P450 46A1:从作用机制到临床应用
Front Aging Neurosci. 2021 Jul 8;13:696778. doi: 10.3389/fnagi.2021.696778. eCollection 2021.
10
Effects of CYP46A1 Inhibition on Long-Term-Depression in Hippocampal Slices and 24S-Hydroxycholesterol Levels in Mice .CYP46A1抑制对小鼠海马切片长期抑郁及24S-羟基胆固醇水平的影响
Front Mol Neurosci. 2020 Oct 29;13:568641. doi: 10.3389/fnmol.2020.568641. eCollection 2020.
J Biol Chem. 2017 Aug 4;292(31):12934-12946. doi: 10.1074/jbc.M117.794909. Epub 2017 Jun 22.
4
BDNF and Hippocampal Synaptic Plasticity.脑源性神经营养因子与海马突触可塑性
Vitam Horm. 2017;104:153-195. doi: 10.1016/bs.vh.2016.10.004. Epub 2016 Nov 29.
5
Targeting PAK1.靶向PAK1。
Biochem Soc Trans. 2017 Feb 8;45(1):79-88. doi: 10.1042/BST20160134.
6
Cytochrome P450 27A1 Deficiency and Regional Differences in Brain Sterol Metabolism Cause Preferential Cholestanol Accumulation in the Cerebellum.细胞色素P450 27A1缺乏与脑甾醇代谢的区域差异导致小脑优先积累胆固醇。
J Biol Chem. 2017 Mar 24;292(12):4913-4924. doi: 10.1074/jbc.M116.774760. Epub 2017 Feb 11.
7
SHANK proteins: roles at the synapse and in autism spectrum disorder.SHANK 蛋白:在突触和自闭症谱系障碍中的作用。
Nat Rev Neurosci. 2017 Mar;18(3):147-157. doi: 10.1038/nrn.2016.183. Epub 2017 Feb 9.
8
The Multifaceted Role of SNARE Proteins in Membrane Fusion.SNARE蛋白在膜融合中的多方面作用
Front Physiol. 2017 Jan 20;8:5. doi: 10.3389/fphys.2017.00005. eCollection 2017.
9
Structure, biochemistry, and biology of PAK kinases.PAK激酶的结构、生物化学及生物学特性
Gene. 2017 Mar 20;605:20-31. doi: 10.1016/j.gene.2016.12.014. Epub 2016 Dec 19.
10
Cholesterol 24-hydroxylase: Brain cholesterol metabolism and beyond.胆固醇24-羟化酶:脑胆固醇代谢及其他
Biochim Biophys Acta. 2016 Dec;1861(12 Pt A):1911-1920. doi: 10.1016/j.bbalip.2016.09.011. Epub 2016 Sep 20.